Analyst Ratings for UroGen Pharma (URGN)
URGN Rating Summary
URGN Price Target Summary
- Highest: $47.00 (Scotiabank)
- Lowest: $30.00 (D. Boral Capital)
- Average: $36.29
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$36.29 (+77.3%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 74%
Avg. $ Target:
$36.29 (+77.3%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 74%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/19/2025 | Piper Sandler | Kelsey Goodwin | New Coverage | Overweight (N/A) |
36.00 (N/A) |
19.71 (20.46) |
3.81% | Details |
| 6/16/2025 | H.C. Wainwright » Updated 8/11/2025 |
Raghuram Selvaraju | Upgrade | Buy (Neutral) |
40.00 (50.00) |
12.03 (20.46) |
70.07% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
